4//SEC Filing
REID CLIFFORD A 4
Accession 0001181431-11-050253
CIK 0001361103other
Filed
Sep 21, 8:00 PM ET
Accepted
Sep 22, 5:44 PM ET
Size
18.0 KB
Accession
0001181431-11-050253
Insider Transaction Report
Form 4
REID CLIFFORD A
DirectorPresident, CEO & Director
Transactions
- Disposition to Issuer
Common Stock, $0.001 par value
2011-09-20$7.30/sh−4,500$32,855→ 314,700 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2011-09-21−8,000→ 50,666 totalExercise: $1.50From: 2009-09-12Exp: 2019-12-27→ Common Stock (50,666 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2011-09-20$1.50/sh+8,000$12,000→ 8,000 total - Sale
Common Stock, $0.001 par value
2011-09-20$7.30/sh−8,000$58,367→ 0 total - Exercise/Conversion
Common Stock, $0.001 par value
2011-09-21$1.50/sh−8,000$12,000→ 8,000 total - Exercise/Conversion
Stock Option (right to buy)
2011-09-20−8,000→ 58,666 totalExercise: $1.50From: 2009-09-12Exp: 2019-12-27→ Common Stock (58,666 underlying) - Disposition to Issuer
Common Stock, $0.001 par value
2011-09-21$6.80/sh−4,500$30,606→ 310,200 total(indirect: By Trust) - Sale
Common Stock, $0.001 par value
2011-09-21$6.81/sh−8,000$54,441→ 0 total
Footnotes (5)
- [F1]The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.90 to $7.42 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F2]These shares are held by the Clifford A. Reid Living Trust, Dated September 3, 1997, Clifford A. Reid, Trustee.
- [F3]The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.80 to $7.44 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F4]The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.655 to $7.06 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- [F5]The shares sold were pursuant to a Rule 10b5-1 plan dated June 16, 2011. The transaction was executed in multiple trades in prices ranging from $6.67 to $7.10 inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
COMPLETE GENOMICS INC
CIK 0001361103
Entity typeother
Related Parties
1- filerCIK 0001134041
Filing Metadata
- Form type
- 4
- Filed
- Sep 21, 8:00 PM ET
- Accepted
- Sep 22, 5:44 PM ET
- Size
- 18.0 KB